Clinical trial for Parkinson Disease
Official title Genetics and Aerobic Exercise to Slow Parkinson's Disease Trial
ClinicalTrials.gov ID: NCT06442033
What this study is testing
- What it's testing
- The study will see if genetics and exercise together change how Parkinson’s disease progresses.
- Who it's for
- People with Parkinson’s disease living in Cleveland or Salt Lake City.
- What's involved
- Participants will do a community exercise program three times a week for a year and have their DNA tested for Parkinson’s risk genes.
- Time commitment
- The program lasts 12 months with exercise sessions three times a week and a DNA test at the start.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adult with a diagnosis of PD by a physician or physician extender
- Hoehn and Yahr stage I-III
- Demonstrate the ability to safely mount and dismount a stationary cycle
- Reliable transportation to the community exercise facility
- Smartphone device for activity data monitoring
You likely can't join if
- Participation in disease modifying PD-related clinical trial or study
- Diagnosis of dementia or any neurocognitive impairment that compromises one's ability to provide informed consent.
- Implanted deep brain stimulation electrodes or focused ultrasound for PD management
- Recommendation for medical clearance using the American College of Sports Medicine (ACSM) Preparticipation Health Screen a.
See the full eligibility criteria
- Adult with a diagnosis of PD by a physician or physician extender
- Hoehn and Yahr stage I-III
- Demonstrate the ability to safely mount and dismount a stationary cycle
- Reliable transportation to the community exercise facility
- Smartphone device for activity data monitoring
- On a stable dose of anti-parkinsonian medication
- Participation in disease modifying PD-related clinical trial or study
- Diagnosis of dementia or any neurocognitive impairment that compromises one's ability to provide informed consent.
- Implanted deep brain stimulation electrodes or focused ultrasound for PD management
- Recommendation for medical clearance using the American College of Sports Medicine (ACSM) Preparticipation Health Screen a.
The study team makes the final eligibility decision.
Where it is enrolling
- Cleveland, Ohio, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Cleveland, Ohio, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.